Blau syndrome-associated uveitis: preliminary results from an international prospective interventional case series

Purpose - Provide baseline and preliminary follow-up results in a 5-year longitudinal study of Blau syndrome. - Design - Multicenter, prospective interventional case series. - Methods - Baseline data from 50 patients from 25 centers worldwide, and follow-up data for patients followed 1, 2, or 3 year...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sarens, Inge (VerfasserIn) , Mackensen, Friederike (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: American journal of ophthalmology
Year: 2017, Jahrgang: 187, Pages: 158-166
ISSN:1879-1891
DOI:10.1016/j.ajo.2017.08.017
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.ajo.2017.08.017
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0002939417303719
Volltext
Verfasserangaben:Inge L. Sarens, Ingele Casteels, Jordi Anton, Brigitte Bader-Meunier, Philippe Brissaud, Gaelle Chédeville, Rolando Cimaz, Andrew D. Dick, Graciella Espada, Jorge Fernandez-Martin, Catherine M. Guly, Eric Hachulla, Miroslav Harjacek, Raju Khubchandani, Friederike Mackensen, Rosa Merino, Consuelo Modesto, Antonio Naranjo, Sheila Oliveira-Knupp, Seza Özen, Christine Pajot, Athimalaipet V. Ramanan, Ricardo Russo, Gordana Susic, Akaluck Thatayatikom, Caroline Thomée, Sebastiaan Vastert, John Bertin, Juan I. Arostegui, Carlos D. Rose, and Carine H. Wouters

MARC

LEADER 00000caa a2200000 c 4500
001 1665972637
003 DE-627
005 20240323101135.0
007 cr uuu---uuuuu
008 190520r20182017xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ajo.2017.08.017  |2 doi 
035 |a (DE-627)1665972637 
035 |a (DE-599)KXP1665972637 
035 |a (OCoLC)1341224947 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sarens, Inge  |e VerfasserIn  |0 (DE-588)1186666757  |0 (DE-627)1665972564  |4 aut 
245 1 0 |a Blau syndrome-associated uveitis  |b preliminary results from an international prospective interventional case series  |c Inge L. Sarens, Ingele Casteels, Jordi Anton, Brigitte Bader-Meunier, Philippe Brissaud, Gaelle Chédeville, Rolando Cimaz, Andrew D. Dick, Graciella Espada, Jorge Fernandez-Martin, Catherine M. Guly, Eric Hachulla, Miroslav Harjacek, Raju Khubchandani, Friederike Mackensen, Rosa Merino, Consuelo Modesto, Antonio Naranjo, Sheila Oliveira-Knupp, Seza Özen, Christine Pajot, Athimalaipet V. Ramanan, Ricardo Russo, Gordana Susic, Akaluck Thatayatikom, Caroline Thomée, Sebastiaan Vastert, John Bertin, Juan I. Arostegui, Carlos D. Rose, and Carine H. Wouters 
264 1 |c 2018 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 6 September 2017 
500 |a Gesehen am 20.05.2019 
520 |a Purpose - Provide baseline and preliminary follow-up results in a 5-year longitudinal study of Blau syndrome. - Design - Multicenter, prospective interventional case series. - Methods - Baseline data from 50 patients from 25 centers worldwide, and follow-up data for patients followed 1, 2, or 3 years at the end of study enrollment. Ophthalmic data were collected at baseline and yearly visits by means of a standardized collection form. - Results - Median age at onset of eye disease was 60 months and duration of eye disease at baseline 145 months. At baseline 38 patients (78%) had uveitis, which was bilateral in 37 (97%). Eight patients (21%) had moderate to severe visual impairment. Panuveitis was found in 38 eyes (51%), with characteristic multifocal choroidal infiltrates in 29 eyes (39%). Optic disc pallor in 9 eyes (12%) and peripapillary nodules in 9 eyes (12%) were the commonest signs of optic nerve involvement. Active anterior chamber inflammation was noted in 30 eyes (40%) at baseline and in 16 (34%), 17 (57%), and 11 (61%) eyes at 1, 2, and 3 years, respectively. Panuveitis was associated with longer disease duration. At baseline, 56 eyes (75%) were on topical corticosteroids. Twenty-six patients (68%) received a combination of systemic corticosteroids and immunomodulatory therapy. - Conclusions - Blau uveitis is characterized by progressive panuveitis with multifocal choroiditis, resulting in severe ocular morbidity despite continuous systemic and local immunomodulatory therapy. The frequency and severity of Blau uveitis highlight the need for close ophthalmologic surveillance as well as a search for more effective therapies. 
534 |c 2017 
700 1 |a Mackensen, Friederike  |d 1974-2016  |e VerfasserIn  |0 (DE-588)123739594  |0 (DE-627)706412761  |0 (DE-576)29385386X  |4 aut 
773 0 8 |i Enthalten in  |t American journal of ophthalmology  |d New York, NY : Elsevier Science, 1918  |g 187(2018), Seite 158-166  |h Online-Ressource  |w (DE-627)320596281  |w (DE-600)2019600-3  |w (DE-576)121466353  |x 1879-1891  |7 nnas  |a Blau syndrome-associated uveitis preliminary results from an international prospective interventional case series 
773 1 8 |g volume:187  |g year:2018  |g pages:158-166  |g extent:9  |a Blau syndrome-associated uveitis preliminary results from an international prospective interventional case series 
856 4 0 |u https://doi.org/10.1016/j.ajo.2017.08.017  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0002939417303719  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190520 
993 |a Article 
994 |a 2018 
998 |g 123739594  |a Mackensen, Friederike  |m 123739594:Mackensen, Friederike  |d 50000  |e 50000PM123739594  |k 0/50000/  |p 15 
999 |a KXP-PPN1665972637  |e 3478370868 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Available online 6 September 2017","Gesehen am 20.05.2019"],"language":["eng"],"recId":"1665972637","person":[{"family":"Sarens","given":"Inge","display":"Sarens, Inge","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Mackensen, Friederike","given":"Friederike","family":"Mackensen"}],"title":[{"title_sort":"Blau syndrome-associated uveitis","subtitle":"preliminary results from an international prospective interventional case series","title":"Blau syndrome-associated uveitis"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"title":[{"title":"American journal of ophthalmology","subtitle":"AJO","title_sort":"American journal of ophthalmology"}],"note":["Gesehen am 21.09.2020","Ungezählte Beil.: Supplement"],"disp":"Blau syndrome-associated uveitis preliminary results from an international prospective interventional case seriesAmerican journal of ophthalmology","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"320596281","pubHistory":["Nachgewiesen 3.Ser. 1.1918 -"],"part":{"pages":"158-166","year":"2018","extent":"9","text":"187(2018), Seite 158-166","volume":"187"},"titleAlt":[{"title":"AJO"}],"name":{"displayForm":["Frank W. Newell, ed.-in-chief [u.a.]"]},"origin":[{"publisherPlace":"New York, NY","dateIssuedKey":"1918","publisher":"Elsevier Science","dateIssuedDisp":"1918-"}],"id":{"issn":["1879-1891"],"zdb":["2019600-3"],"eki":["320596281"]},"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Inge L. Sarens, Ingele Casteels, Jordi Anton, Brigitte Bader-Meunier, Philippe Brissaud, Gaelle Chédeville, Rolando Cimaz, Andrew D. Dick, Graciella Espada, Jorge Fernandez-Martin, Catherine M. Guly, Eric Hachulla, Miroslav Harjacek, Raju Khubchandani, Friederike Mackensen, Rosa Merino, Consuelo Modesto, Antonio Naranjo, Sheila Oliveira-Knupp, Seza Özen, Christine Pajot, Athimalaipet V. Ramanan, Ricardo Russo, Gordana Susic, Akaluck Thatayatikom, Caroline Thomée, Sebastiaan Vastert, John Bertin, Juan I. Arostegui, Carlos D. Rose, and Carine H. Wouters"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"id":{"eki":["1665972637"],"doi":["10.1016/j.ajo.2017.08.017"]}} 
SRT |a SARENSINGEBLAUSYNDRO2018